Loading clinical trials...

Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT00190866

Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome

To assess the efficacy of Duloxetine compared with placebo in the treatment of pain in patients with Fibromyalgia syndrome, with or without major depressive disorder.

Lead sponsor: Eli Lilly and Company•33 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

NCT07226648 · Fibromyalgia

RECRUITING

The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor

NCT07358754 · Fibromyalgia

RECRUITING

The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes

NCT05901259 · Cerebral Palsy, Multiple Sclerosis, and more

RECRUITINGPhase 1

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

NCT03759522 · Fibromyalgia, Chronic Fatigue Syndrome, and more

RECRUITINGPhase 3

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

NCT07398417 · Fibromyalgia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 6, 2007Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment210

Start dateJun 2005

Last updatedNov 6, 2007

Condition

Fibromyalgia

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Peoria, Arizona

Phoenix, Arizona

For additional information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician

Tucson, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 6, 2007Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions